HORIZON-HLTH-2027-01-DISEASE-05:
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential (RIA)
Deadline: 13.04.2027
♦ Cross-cutting priorities: SSH
♦ Type of MGA: Action Grant Budget-Based
♦ Specific Condition: Funding will be allocated to ensure a balanced portfolio across the targeted viruses by supporting, within the available budget, not only the highest-ranked proposals overall but also the top-ranked proposals for different viruses, provided all evaluation thresholds are met: Portfolio Approach.
